Peter Collins has been appointed senior vice president of business development at DxS Ltd, a personalised medicine company located in Manchester UK. Mr Collins has more than 25 years of experience in the diagnostics industry having held senior positions at a number of companies including Vysis Europe, now part of Abbott Molecular Diagnostics.
DxS also announced the appointment of Jeff Devlin, the company’s chief operating officer, to the board of directors. A former executive at Shire Plc, Mr Devlin joined DxS in January 2009.
Copyright 2009 Evernow Publishing Ltd